Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Text availability
Article attribute
Article type
Publication date

Search Results

336 results
Filters applied: . Clear all Results are displayed in a computed author sort order. Results by year timeline is unavailable
Page 1
Neoadjuvant therapy for surgically staged IIIA N2 non-small cell lung cancer (NSCLC).
Elias AD, Skarin AT, Leong T, Mentzer S, Strauss G, Lynch T, Shulman L, Jacobs C, Abner A, Baldini EH, Frei E 3rd, Sugarbaker DJ. Elias AD, et al. Lung Cancer. 1997 May;17(1):147-61. doi: 10.1016/s0169-5002(97)00658-2. Lung Cancer. 1997. PMID: 9194034 Clinical Trial.
Continuous infusion cisplatin 25 mg/m2/day 1-5, 5-fluorouracil 800 mg/m2/day 2-5, and high-dose leukovorin 500 mg/m2/day 1-5 (PFL) given every 4 weeks achieved a 41% response rate in metastatic NSCLC (Lynch TJ, Kalish LA, Kass F, Strauss G, Elias A, Skarin A, Shulma …
Continuous infusion cisplatin 25 mg/m2/day 1-5, 5-fluorouracil 800 mg/m2/day 2-5, and high-dose leukovorin 500 mg/m2/day 1-5 (PFL) given eve …
Trials of 9-amino-20(S)-camptothecin in Boston.
Eder JP, Rubin E, Stone R, Bryant M, Xu G, Supko J, Kinchla N, Lynch T, Hurwitz S, Rodriguez D, Shapiro C, Toppmeyer D, Grossbard M, Vosburg E, Huberman M, Schnipper L, Shulman L, Kufe DW. Eder JP, et al. Ann N Y Acad Sci. 1996 Dec 13;803:247-55. doi: 10.1111/j.1749-6632.1996.tb26394.x. Ann N Y Acad Sci. 1996. PMID: 8993518 Clinical Trial.
336 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page